Top Purchases
The top purchases made by insiders yesterday. Remember, returns and win rates are calculated using the previous purchase trades by the insider.
Director at ISSUER DIRECT CORP ($ISDR)
The Director purchased 10,498 shares at $11.90/share ($125K total) which increased their vested holdings by 1.9%. The current price is $11.99 (+0.8%). Their median purchase size is $299K and this is their 13th largest purchase out of 15 all time. (SEC Source)
Historic Returns
1m returns: 20% weighted | 5% median | 70% win rate (7/10)
3m returns: 121% weighted | 196% median | 100% win rate (6/6)
6m returns: 119% weighted | 88% median | 100% win rate (7/7)
1y returns: 80% weighted | 166% median | 83% win rate (5/6)
Chief Financial Officer at MARKETWISE, INC. ($MKTW)
The Chief Financial Officer purchased 11,363 shares at $1.73/share ($19,667.08 total) which increased their vested holdings by 1.4%. The current price is $1.77 (+2.3%). Their median purchase size is $19,547.30 and this is their 1st largest purchase out of 2 all time. (SEC Source)
Historic Returns
1m returns: 18% weighted | 18% median | 100% win rate (1/1)
3m returns: 149% weighted | 149% median | 100% win rate (1/1)
6m returns: 35% weighted | 35% median | 100% win rate (1/1)
1y returns: N/A
10% Owner at Cardlytics, Inc. ($CDLX)
The 10% Owner purchased 350,000 shares at $14.16/share ($4.96M total) which increased their vested holdings by 5.8%. The current price is $15.24 (+7.6%). Their median purchase size is $2.48M and this is their 15th largest purchase out of 61 all time. (SEC Source)
Historic Returns
1m returns: 14% weighted | 20% median | 81% win rate (34/42)
3m returns: 43% weighted | 62% median | 88% win rate (37/42)
6m returns: 39% weighted | 42% median | 74% win rate (31/42)
1y returns: 63% weighted | 119% median | 79% win rate (33/42)
CHIEF SCIENTIFIC OFFICER at Immuneering Corp ($IMRX)
The CHIEF SCIENTIFIC OFFICER purchased 7,000 shares at $2.86/share ($20,020.00 total) which increased their vested holdings by 2.1%. The current price is $2.73 (-4.5%). Their median purchase size is $15,010.00 and this is their 2nd largest purchase out of 4 all time. (SEC Source)
Historic Returns
1m returns: 45% weighted | 15% median | 67% win rate (2/3)
3m returns: 56% weighted | 61% median | 67% win rate (2/3)
6m returns: 12% weighted | 61% median | 67% win rate (2/3)
1y returns: -7% weighted | 31% median | 67% win rate (2/3)
Note: 1 other insiders also purchased the stock
Top Sales
The top sales made by insiders yesterday. Remember, returns and win rates are calculated using the previous sell trades by the insider. For sell transactions, “win rate” is the percent of profitable trades. If the “win rate” is low, that means the stock typically falls after the insider sells.
Director at Avidity Biosciences, Inc. ($RNA)
The Director sold 5,000 shares at $23.97/share ($120K total) which decreased their vested holdings by 1.5%. The current price is $24.10 (+0.5%). Their median sale size is $402K and this is their 11th largest sale out of 14 all time. (SEC Source)
Historic Returns
1m returns: -17% weighted | -15% median | 25% win rate (3/12)
3m returns: -34% weighted | -30% median | 0% win rate (0/11)
6m returns: 24% weighted | -50% median | 9% win rate (1/11)
1y returns: -58% weighted | -51% median | 9% win rate (1/11)
Chief Financial Officer at WEX Inc. ($WEX)
The Chief Financial Officer sold 309 shares at $233.24/share ($72,071.16 total) which decreased their vested holdings by 5.3%. The current price is $236.78 (+1.5%). Their median sale size is $116K and this is their 8th largest sale out of 8 all time. (SEC Source)
Historic Returns
1m returns: -7% weighted | -7% median | 0% win rate (0/6)
3m returns: -30% weighted | -28% median | 0% win rate (0/6)
6m returns: -45% weighted | -42% median | 0% win rate (0/6)
1y returns: -46% weighted | -43% median | 0% win rate (0/6)
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
